Provided by Tiger Trade Technology Pte. Ltd.

Corgi Beauty, Skincare & Aesthetics ETF

28.50
+0.39691.41%
Volume:341
Turnover:10K
Market Cap:1.43M
PE:- -
High:28.50
Open:28.45
Low:28.45
Close:28.11
52wk High:29.89
52wk Low:24.32
Shares:50.00K
Float Shares:50.00K
Volume Ratio:2.91
T/O Rate:0.68%
Dividend:- -
Dividend Rate:- -
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Biogen Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Sep 22

Estee Lauder Cos. Cl a Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Sep 22

100 Million UUSD Tokens Debut on Robinhood Chain as Tokenized Equity Push Accelerates

Stock News
·
Sep 21

AbbVie, Iambic Sign Multiyear Drug Discovery Deal

MT Newswires Live
·
Sep 21

AbbVie Partners with Iambic to Accelerate AI-Driven Small-Molecule Drug Discovery

Reuters
·
Sep 21

Abbvie and Iambic Announce Collaboration to Accelerate AI-Driven Drug Discovery

THOMSON REUTERS
·
Sep 21

Abbvie - Iambic to Receive Upfront Payment, Milestone Payments, and Tiered Royalties from Collaboration

THOMSON REUTERS
·
Sep 21

Abbvie - Partnership to Accelerate Small Molecule Drug Discovery in Immunology, Neuroscience, Oncology

THOMSON REUTERS
·
Sep 21

Adarx Pharmaceuticals: IPO Price Expected Between $15 and $17 Per Share

Reuters
·
Sep 21

LIVE Markets-the Capex Boom, Minus AI

Reuters
·
Sep 21

LIVE Markets-Big Beauty Faces Growing Threat from AI, Smaller Rivals

Reuters
·
Sep 21

ADARx Pharmaceuticals to Sell 21.9 Million Shares at $15-$17 Each in IPO

Dow Jones
·
Sep 21

Drug Developer ADARx Seeks $1.74 Billion Valuation in US IPO

Reuters
·
Sep 21

Align Technology Inc. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Sep 19

AbbVie presents new Vraylar data at Psych Congress 2026

TIPRANKS
·
Sep 18

AbbVie Says Real-World Studies Show Vraylar Improves Symptoms in MDD, Bipolar I Depression

Reuters
·
Sep 18

Estee Lauder Cos. Cl a Stock Underperforms Thursday When Compared to Competitors

Dow Jones
·
Sep 18

Hims & Hers CTO Mohamed Elshenawy Sells 7,954 Shares Worth $225,421.06

Reuters
·
Sep 18

AbbVie Targets Dry Eye Market Upside With New ABBV-444 Trial Update

TIPRANKS
·
Sep 18

US Regulators Urge More Research on Testosterone Therapy for Women as Experts Debate Benefits, Risks

Reuters
·
Sep 18